- Trials with a EudraCT protocol (610)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
610 result(s) found for: Elective surgery.
Displaying page 1 of 31.
EudraCT Number: 2011-004894-96 | Sponsor Protocol Number: 2011-10-03 | Start Date*: 2012-03-20 | ||||||||||||||||
Sponsor Name:Mikko Hippeläinen [...] | ||||||||||||||||||
Full Title: ORAL ABSORPTION OF OXYCODONE AFTER CARDIAC BYPASS SURGERY | ||||||||||||||||||
Medical condition: | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001860-45 | Sponsor Protocol Number: hospitalplato1 | Start Date*: 2020-01-14 |
Sponsor Name:Hospital Plató | ||
Full Title: Impact of topical antibiotic prophylaxis with Gentamicin on SSI rate on elective incisional hernia surgery: a randomised clinical trial. | ||
Medical condition: Surgical site infection on incisional hernia remains still high (8-14%). Its apperance is related to long and costfull treatments (daily cures, antibiotics and hospital readmission) and it is also ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-000566-36 | Sponsor Protocol Number: 14072010 | Start Date*: 2011-09-20 | |||||||||||
Sponsor Name:Hannu Kokki | |||||||||||||
Full Title: Laskimoon annetun ketoprofeenin ja deksketoprofeenin aiheuttama kirvely | |||||||||||||
Medical condition: Potilaat, joille on tarkoitus tehdä ei-päivystyksellinen toimenpide, ja joilla on tarkoitus käyttää laskimoon annettavaa ketoprofeenia ennakoivana kipulääkityksenä. Potilaiden tulee kuulua anestesi... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005291-34 | Sponsor Protocol Number: NL41467 | Start Date*: 2014-02-14 | ||||||||||||||||
Sponsor Name:AMC, Amsterdam | ||||||||||||||||||
Full Title: Perioperative intravenous insulin, GIK or GLP-1 treatment in DM | ||||||||||||||||||
Medical condition: Patients with diabetes mellitus type 2 who will undergo non-cardiac surgery | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-001551-22 | Sponsor Protocol Number: RECIPE2014 | Start Date*: 2014-12-18 |
Sponsor Name:Charité Universitätsmedizin | ||
Full Title: Reduction of postoperative wound infections by antiseptica | ||
Medical condition: Laparotomy wound after closure of the fascia after visceral surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-004901-41 | Sponsor Protocol Number: PREFERCABG01 | Start Date*: 2018-04-19 |
Sponsor Name:Hospital District of Southwestern Finland | ||
Full Title: A Phase IV Double-blind, Randomised, Parallel Group Comparison of the Efficacy and Safety of Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Elect... | ||
Medical condition: Patients undergoing elective coronary artery bypass grafting surgery, the study investigates the prevention of postoperative infections and blood transfusions. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-010173-20 | Sponsor Protocol Number: A3051113 | Start Date*: 2009-08-06 | |||||||||||
Sponsor Name:Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK | |||||||||||||
Full Title: A MULTICENTER, OPEN LABEL STUDY TO INVESTIGATE THE FEASIBILITY AND EFFICACY OF A SMOKING CESSATION PROGRAM WITH VARENICLINE IN PATIENTS UNDERGOING ELECTIVE SURGERY | |||||||||||||
Medical condition: Smoking cessation in patients scheduled for elective surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001128-19 | Sponsor Protocol Number: CV185-010 | Start Date*: 2004-11-02 |
Sponsor Name:Bristol-Myers Squibb International Corporation | ||
Full Title: A Phase 2 Randomized, Double Blinded (BMS-562247 and enoxaparin), Active-Controlled (enoxaparin and warfarin), Parallel-Arm, Dose Response Study of the Oral Factor Xa Inhibitor BMS-562247 in Subjec... | ||
Medical condition: Prevention of asymptomatic and symptomatic deep vein thrombosis (DVT) and non-fatal pulmonary embolism (PE) in subjects undergoing knee replacement surgery. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-007162-38 | Sponsor Protocol Number: 19.4.335 | Start Date*: 2008-03-17 |
Sponsor Name:NV Organon | ||
Full Title: A multi-center, open label trial, to show efficacy and safety of 4.0 mg.kg-1 sugammadex administered at a depth of neuromuscular blockade of 1-2 PTC induced by rocuronium in Chinese and European AS... | ||
Medical condition: Not applicable | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DK (Completed) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-001988-21 | Sponsor Protocol Number: 1160.48 | Start Date*: 2004-11-01 |
Sponsor Name:Boehringer Ingelheim Finland Ky | ||
Full Title: A phase III randomised, parallel group, double-blind, active controlled study to investigate the efficacy and safety of two different dose regimens of orally administered dabigatran etexilate capsu... | ||
Medical condition: Prevention of venous thromboembolism following primary elective total hip replacement surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) SE (Completed) AT (Completed) DE (Completed) HU (Completed) DK (Completed) CZ (Completed) IT (Completed) ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-001317-34 | Sponsor Protocol Number: 1160.25 | Start Date*: 2004-11-01 |
Sponsor Name:Boehringer Ingelheim Finland Ky | ||
Full Title: A phase III, randomised, parallel-group, double-blind, active controlled study to investigate the efficacy and safety of two different dose regimens of orally administered dabigatran etexilate caps... | ||
Medical condition: Prevention of venous thromboembolism following primary elective total knee replacement surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) SE (Completed) DE (Completed) AT (Completed) HU (Completed) DK (Completed) CZ (Completed) IT (Completed) ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-005246-31 | Sponsor Protocol Number: ANEST01 | Start Date*: 2017-03-20 |
Sponsor Name:Complexo Hospitalario Universitario de Pontevedra | ||
Full Title: Analgesic effectiveness of ultrasound-guided bilateral Transversus Abdominis Plane (TAP) block technique for laparoscopic radical prostatectomy: a prospective, randomized, simple-blind study | ||
Medical condition: Patients scheduled for elective laparoscopic radical prostatectomy surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001565-15 | Sponsor Protocol Number: 01-07 | Start Date*: 2007-08-27 | |||||||||||
Sponsor Name:Universityhospital Ulm | |||||||||||||
Full Title: Konzentrationen von Ertapenem in kolorektalem Gewebe. | |||||||||||||
Medical condition: The purpose of this study is to determine the tissue kinetics of ertapenem in colorectal tissue from three hours up to six hours (25% of dosing interval) after administration of ertapenem before a ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002161-39 | Sponsor Protocol Number: CV185-034 | Start Date*: 2006-12-05 |
Sponsor Name:Bristol-Myers Squibb International Corporation | ||
Full Title: A Phase 3 Randomized, Double-Blind, Active-Controlled (Enoxaparin), Parallel Group, Multi-Center Study to Evaluate the Safety and Efficacy of Oral Apixaban in Subjects Undergoing Elective Total Kne... | ||
Medical condition: Subjects undergoing elective total knee replacement surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) SE (Completed) HU (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-000464-95 | Sponsor Protocol Number: IPC-05-2004 | Start Date*: 2005-10-14 |
Sponsor Name:Inotek Pharmaceuticals Corporation | ||
Full Title: A phase II randomized, double-blind, placebo-controlled, multi-center study to evaluate tolerability, safety pharmacokinetics and efficacy of intravenous INO-1001 in high-risk subjects undergoing c... | ||
Medical condition: INO-1001 is being developed for the treatment of high-risk subjects undergoing cardiopulmonary bypass (CPB) for coronary revascularization and/or valve surgery. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2008-004416-13 | Sponsor Protocol Number: 150-CL-040 | Start Date*: 2009-05-06 | |||||||||||
Sponsor Name:Astellas Pharma Europe B.V. | |||||||||||||
Full Title: Protocol for Phase IIb Study of YM150. A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in S... | |||||||||||||
Medical condition: Prevention of venous thromboembolism after hip replacement surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) LV (Completed) SK (Completed) DE (Completed) SE (Completed) DK (Completed) LT (Completed) EE (Completed) CZ (Completed) HU (Completed) GB (Completed) ES (Completed) FI (Completed) NL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000360-30 | Sponsor Protocol Number: FEPODPara2021-1 | Start Date*: 2021-05-03 |
Sponsor Name:Helsinki University Hospital | ||
Full Title: Determination of serum paracetamol concentration with an electrochemical measurement tool from blood and saliva samples in patients using also other medication. | ||
Medical condition: Patients with any medical condition that requires regular medication and who are undergoing elective surgery. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002644-40 | Sponsor Protocol Number: B3451002 | Start Date*: 2015-05-27 | ||||||||||||||||
Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, NY 10017 | ||||||||||||||||||
Full Title: A Phase 2B, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Staphylococcus Aureus 4-Antigen Vaccine (SA4Ag) in Adults Undergoing Elective Posterior Instrum... | ||||||||||||||||||
Medical condition: Prophylaxis for prevention of Post-operative S. aureus infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) GB (Prematurely Ended) DE (Prematurely Ended) HU (Completed) AT (Prematurely Ended) SE (Prematurely Ended) BG (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-004878-26 | Sponsor Protocol Number: 26842468452 | Start Date*: 2013-02-07 |
Sponsor Name:Karolinska University Hospital Solna | ||
Full Title: Antibiotic prophylaxis in patients undergoing primary or secondary breast reconstruction with implants, a randomized parallel two armed prospective clinical trial. | ||
Medical condition: The incidence of postoperative infections in patients with breast cancer or a history of breast cancer, after elective surgery with primary or secondary first-time breast reconstruction with implan... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: SE (Prohibited by CA) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001167-22 | Sponsor Protocol Number: 43488 | Start Date*: 2017-06-29 |
Sponsor Name: | ||
Full Title: Spinal Morphine in laparoscopic gastro-intestinal surgery | ||
Medical condition: Patients with indications for laparoscopic gastro-intestinal surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
